Evidence map›Paper›PMID 40823828›Full record

ArticlemBio2025

Temperate phages increase antibiotic effectiveness in a

Rabia Fatima, Gayatri Nair, Jordan Mayol, Lesley T MacNeil, Alexander P Hynes

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Prophage: agent provocateur?Archives of microbiology · 2026
    Review
  5. Review
  6. Review
  7. Broad-spectrum phage cocktail targetingFrontiers in microbiology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Re-evaluating what makes a phage unsuitable for therapy.npj antimicrobials and resistance · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rabia FatimaDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.ORCID 0009-0008-6590-3311
Gayatri NairDepartment of Medicine, McMaster University, Hamilton, Ontario, Canada.
Jordan MayolDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
Lesley T MacNeilDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
Alexander P HynesDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0002-7058-6006

Funding

Farncombe Family Chair in Phage BiologyNatural Sciences and Engineering Research Council of Canada 2018-05996Natural Sciences and Engineering Research Council of Canada CGS
6 · The paper itself

Abstract

The bactericidal nature of obligately lytic bacterial viruses (phages) is of increasing interest for the treatment of drug-resistant bacterial infections, often alongside antibiotics. By contrast, temperate phages are largely ignored due to their ability to lie dormant within the bacterial host. However, these phages often undergo a lytic cycle. Furthermore, in their dormant state, they switch to lytic replication in response to triggers, such as antibiotics, that stress the bacterial host. Recent reports of antibiotics synergizing with temperate phages IMPORTANCE: Bacterial viruses (phages), which can go dormant in their host, are not considered suitable for phage therapy. Building on prior work showing antibiotics synergize with these phages by preventing dormancy, we test the ability of temperate phages-in combination with antibiotics-in an animal model of infection. Not only were the combinations extremely effective at doses that would do nothing alone, even when the bacterium was resistant to the antibiotics-but we also found that whether the dormant phage pre-existed (as it does in about 75% of bacteria) or not determined the success of antibiotic treatments, suggesting many antibiotic treatments are already a form of "accidental" phage therapy.

Indexed as

Anti-Bacterial AgentsBacteriophagesCaenorhabditis elegansPhage TherapyPseudomonas aeruginosaPseudomonas InfectionsAnimalsCiprofloxacinDisease Models, AnimalAnti-Bacterial AgentsCiprofloxacinbacteriophage therapyC. elegansinductionlysogenyphage antibiotic synergytemperate phages

Identifiers

PMID40823828
PMCPMC12421866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.